Skip to main content
SpringerLink
Log in
Book cover

Lessons from Animal Diabetes VI pp 317–332Cite as

Role of immune and non-immune aspects of genetics in different expressions of diabetes in db/db mice

  • Chapter

  • 110 Accesses

Part of the book series: Rev.Ser.Advs.Research Diab.Animals (Birkhäuser) ((RSARDA,volume 6))

Abstract

The availability of several animal species with diabetes contributed significantly to the understanding of the pathogenesis of the disease and to the development of novel treatment and prevention strategies. Additional contribution derived from investigation of spontaneous and induced forms of diabetes resembling human IDDM and NIDDM, two entities distinguished by their pathogenic background and their clinical presentation. Among the animal models the db/db mouse, with its autosomal recessive db (diabetes) mutated gene on chromosome 4, is of particular importance for the understanding of the complexity of diabetes, since it displays characteristics of NIDDM during the initial stage of the syndrome and of IDDM during the final stage as a result of B-cell necrosis and islet atrophy. Homozygosity for the db gene in mice is characterized by hyperglycemia and hyperinsulinemia early in the process of diabetes, followed by a stage of insulin deficiency and overt IDDM, although the clinical expression differs according to the different genetic background of the mouse. The increased susceptibility of the db/db mouse to the diabetogenic action of viruses and chemical compounds before overt diabetes appears makes this animal an ideal model to study the mechanisms by which diabetogenic or antidiabetogenic genes interact with other genes and/or environmental factors. Previous reviews described different aspects of diabetes in the db/db mouse,1–3 whereas we focus on the role of genetically determined immune and non-immune mechanisms and describe the effect of environmental factors in inducing different expressions of diabetes in db/db mice.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Coleman DL, Hummel KP. Studies with the mutation, diabetes, in mouse. Diabetologia 3:328–48, 1967.

    Article  Google Scholar 

  2. Leiter EH. The genetics of diabetes susceptibility in mice. FASEB J 3:2231–41, 1989.

    PubMed  CAS  Google Scholar 

  3. Shafrir E. Animal models of non-insulin-dependent diabetes. Diabetes Metab Rev 8:179–208, 1992.

    Article  PubMed  CAS  Google Scholar 

  4. Hummel KP, Dickie MM, Coleman DL. Diabetes, a new mutation in the mouse. Science 153:1127–28, 1966.

    Article  PubMed  CAS  Google Scholar 

  5. Lyon MG, Searl AG. Genetic strains and variants of the laboratory mouse. Oxford University Press, Oxford, pp 265–6, 1989.

    Google Scholar 

  6. Bahary N, Leibel RL, Joseph L, et al. Molecular mapping of the mouse db mutation. Proc Natl Acad Sci USA 87:8642–6, 1990.

    Article  PubMed  CAS  Google Scholar 

  7. Truett G, Bahary N, Friedman J, et al. Rat obesity gene fatty (fa) maps to chromosome 5: Evidence for homology with the mouse gene diabetes (db). Proc Natl Acad Sci USA 88:7806–9, 1991.

    Article  PubMed  CAS  Google Scholar 

  8. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–32, 1994.

    Article  PubMed  CAS  Google Scholar 

  9. Molina JM, Premdas FH, Klenck RE, et al. The dynamic insulin secretory response of isolated pancreatic islets of the diabetic mouse. Evidence for a gene dosage effect on insulin secretion. Diabetes 33:1120–23, 1984.

    Article  PubMed  CAS  Google Scholar 

  10. Chick WL, Lavine RL, Like A A. Studies in the diabetic mutant mouse. 5. Glucose tolerance in mice homozygous and heterozygous for the diabetes (db) gene. Diabetologia 6:527, 1970.

    Google Scholar 

  11. Hummel KP, Coleman DL, Lane PW. The influence of genetic background on expression of mutations at the diabetes locus in the mouse. 1. C57B 1/K and C57BL/6J strains. Biochem Genet 7:1–13, 1972.

    Article  PubMed  CAS  Google Scholar 

  12. Kaku K, Province M, Permutt MA. Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: Evidence for polygenic control. Diabetologia 32:636–43, 1989.

    PubMed  CAS  Google Scholar 

  13. Leiter EH, Le PH, Coleman DL. Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice: Control by gender-associated, MHC-unlinked traits. Immunogenetics 26:6–13, 1987.

    Article  PubMed  CAS  Google Scholar 

  14. Coleman DL, Hummel KP. Influence of genetic background on expression of mutations at the diabetes locus in the mouse. 2. Studies on background modifiers. Isr J Med Sci 11:708–13, 1975.

    PubMed  CAS  Google Scholar 

  15. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516–42, 1994.

    PubMed  CAS  Google Scholar 

  16. Rich SS, French LR, Sprafka JM, et al. HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: The Wadena City Health Study. Diabetologia 36:234–8, 1993.

    Article  PubMed  CAS  Google Scholar 

  17. Leiter EH, Coleman DL, Hummel KP. The influence of genetic background on the expression of mutation at the diabetes locus in the mouse. 3. Effect of H-2 haplotype and sex. Diabetes 30:1029–34, 1981.

    Article  PubMed  CAS  Google Scholar 

  18. Leiter EH. Genetic control of pathogenesis of diabetes in C3H mice. Influence of the major histocompatibility complex. Diabetes 33:1068–71, 1984.

    Article  PubMed  CAS  Google Scholar 

  19. Prochazka M, Premdas F, Leiter E, et al. Estrone treatment dissociates primary versus secondary consequences of “diabetes” gene expression in mice. Diabetes 35:725–8, 1986.

    Article  PubMed  CAS  Google Scholar 

  20. Leiter EH, Chapman H. Obesity-induced diabetes (diabesity) in C57BLKS/J mice produces aberant trans-regulation of sex steroid sulfotransferase genes. J Clin Invest 93:2007–13, 1994.

    Article  PubMed  CAS  Google Scholar 

  21. Leiter EH, Chapman HD, Coleman DL. The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia. Endocrinology 124:912–22, 1989.

    Article  PubMed  CAS  Google Scholar 

  22. Gunnarson R. Function of the pancreatic B-cell during the development of hyperglycaemia in mice homozygous for the mutation “diabetes”(db) and “misty” (m). Diabetologia 11:431–8, 1975.

    Article  Google Scholar 

  23. Bloch KO, Poltorak VV, Brindak Ol, et al. Importance of db gene for the development of low dose streptozotocin diabetes in C57BL/KsJ mice. Probl Endokrinol Mosk 34:73–5, 1988 (in Russian).

    Google Scholar 

  24. Gill AM, Leiter EH, Powell JG, et al. Dexamethasone-induced hyperglycemia in obese Avy/a (viable yellow) female mice entails preferential induction of a hepatic estrogen sulfotransferase. Diabetes 43:999–1004, 1994.

    Article  PubMed  CAS  Google Scholar 

  25. Jackson R, Rassi N, Crump T, et al. The BB diabetic rat: Profound T-cell lymphocytopenia. Diabetes 30:887–9, 1981.

    Article  PubMed  CAS  Google Scholar 

  26. Dardenne M, Savino W, Gastinel LN, et al. Thymic dysfunction in the mutant diabetec (db/db) mouse. J Immunol 130:1195–99, 1983.

    PubMed  CAS  Google Scholar 

  27. Boillot D, Assan R, Dardenne M, et al. T-lymphopenia and T-cell imbalance in diabetic db/db mice. Diabetes 35:198–203, 1986.

    Article  PubMed  CAS  Google Scholar 

  28. Sai P, Kremer M, Maurel C. Antibodies spontaneously bound to islet cells in diabetic C57BL/KsJ db/db mice. Diabetologia 27:139–42, 1984.

    Article  PubMed  Google Scholar 

  29. Leiter EH, Yoon JW, Kuff EL. Spontaneous autoantibody production against insulin and retrovirus distinguishes C57Bl/KsJ from C57B1/6J mice. Diabetes 34(Suppl 1):319A, 1985.

    Google Scholar 

  30. Debray-Sachs M, Dardenne M, Sai P, et al. Anti-islet immunity and thymic disfuction in the mutant diabetic C57BLKS/J db/db mouse. Diabetes 32:1048–54, 1983.

    Article  PubMed  CAS  Google Scholar 

  31. Nishimura M, Miyamoto H. Immunological influence of A vy, db, ob and nu genes placed on the inbred NOD background as murine models for human type 1 diabetes. J Immunogen 14:127–30, 1984.

    Article  Google Scholar 

  32. Prochazka M, Leiter EH, Serreze DV, et al. Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science 237:286–9, 1987.

    Article  PubMed  CAS  Google Scholar 

  33. Pancrel P, Meretey K, Illyes Y. Immunogenetic study of the familial accumulation of type 1 (IDDM) diabetes mellitus and rheumatoid arthritis. Diabetologia 30:566A, 1987.

    Google Scholar 

  34. Huang SW, Maclaren NK. Antibodies to nucleic acids in juvenile onset diabetes. Diabetes 27:1105–11, 1978.

    Article  PubMed  CAS  Google Scholar 

  35. Petri M, Yoo SS. Insulin resistance in systemic lupus erythematosus. Arthritis Rheumat 37:S323, 1994.

    Google Scholar 

  36. Murphy ED, Roth JB. A Y chromosome associated factor in strain BB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheumat 22:1188, 1979.

    Article  PubMed  CAS  Google Scholar 

  37. Leiter EH, Prochazka M, Shultz LD. Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice. J Immunol 138:3224–29, 1987.

    PubMed  CAS  Google Scholar 

  38. Steinberg AD, Krieg AM, Gourley MF, et al. Theoretical and experimental approaches to generalized autoimmunity. Immunol Rev 118:129–63, 1990.

    Article  PubMed  CAS  Google Scholar 

  39. Kolb H, Freytag G, Kiesel U, et al. Spontaneous autoimmune reaction against pancreatic islets in mouse strains with generalized autoimmune disease. Diabetologia 19:216–21, 1980.

    Article  PubMed  CAS  Google Scholar 

  40. Bloch KO, Poltorak VV. Diabetogenic effects of the db (diabetes) gene in mice with inherited immunopathology. In: Hormonal regulation in health and pathology. Kharkov, USSR, p 11, 1989 (in Russian).

    Google Scholar 

  41. Bloch KO, Poltorak VV. Expression of thedb (diabetes) gene in mice with hereditary load by generalized autoimmune pathology. Tsitol Genet 25:40–5, 1991 (in Russian).

    Google Scholar 

  42. Leiter EH. Type C retrovirus production by pancreatic beta cells. Association with accelerated pathogenesis in C3H-db/db (“diabetes”) mice. Am J Pathol 119:22–32, 1985.

    PubMed  CAS  Google Scholar 

  43. Leiter EH, Kuff EL. Intracisternal Type A particles in murine pancreatic B cells. Immunocytochemical demonstration of increased antigen (p73) in genetically diabetic mice. Am J Pathol 114:46–55, 1984.

    PubMed  CAS  Google Scholar 

  44. Leiter EH, Fewell JW, Kuff EL. Glucose induces intracisternal type A retroviral gene transcription and translation in pancreatic beta cells. J Exp Med 163:87–100, 1986.

    Article  PubMed  CAS  Google Scholar 

  45. Appel MC, Rossini AA, Williams RM, et al. Viral studies in streptozotocin-induced pancreatic insulitis. Diabetologia 15:327–36, 1978.

    Article  PubMed  CAS  Google Scholar 

  46. Fujita H, Fujino H, Nonaka K, et al. Retrovirus-like particles in pancreatic beta-cells of NOD (non-obese diabetic) mice. Biomed Res 59:67–70, 1984.

    Google Scholar 

  47. Swenne I. Pancreatic beta-cell growth and diabetes mellitus. Diabetologia 35:193–201, 1992.

    Article  PubMed  CAS  Google Scholar 

  48. Eizirik DL, Sandler S, Palmer JP. Repair of pancreatic beta-cells. A relevant phenomenon in early IDDM? Diabetes 42:1383–91, 1993.

    Article  PubMed  CAS  Google Scholar 

  49. Sweene I, Andersson A. Effect of genetic background on the capacity for islet cell replication in mice. Diabetologia 27:464–7, 1984.

    Article  Google Scholar 

  50. Andersson A. The influence of hyperglycaemia, hyperinsulinaemia and genetic background on the fate of intrasplenically implanted mouse islets. Diabetologia 25:269–72, 1983.

    Article  PubMed  CAS  Google Scholar 

  51. Leiter EH. Analysis of differential survival of syngeneic islet transplanted into hyperglycemic C57BL/6J versus C57BLKS/J mice. Transplantation 44:401–6, 1987.

    Article  PubMed  CAS  Google Scholar 

  52. Leiter EH. Control of spontaneous glucose intolerance, hyperinsulinemia, and islet hyperplasia in nonobese C3H.SW male mice by Y-linked locus and adrenal gland. Metabolism 37:689–96, 1988.

    Article  PubMed  CAS  Google Scholar 

  53. Orland MJ, Permutt MA. Genetic susceptibility to diabetes in inbred strains of mice: Measurements of proinsulin NA and response to dexamethasone. Diabetologia 30:934–9, 1987.

    Article  PubMed  CAS  Google Scholar 

  54. Gibbs EM, Stock JL, Mccoid SC, et al. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 4:1512–18, 1995.

    Article  Google Scholar 

  55. Okamoto H. Regulation of proinsulin synthesis in pancreatic islets and new aspect to insulin-dependent diabetes. Mol Cell Biochem 37:43–61, 1981.

    Article  PubMed  CAS  Google Scholar 

  56. Takieten N, Rakieten M, Nadkarni M. Studies on the diabetogenic action of streptozotocin. Cancer Chemother Rep 29:91, 1963.

    Google Scholar 

  57. Kolb H, Kroncke KD. IDDM. Lessons from the low-dose streptozotocin model in mice. Diabetes Rev 1:116–26, 1993.

    Google Scholar 

  58. Bloch KO, Poltorak VV, Brindak OI. Effect of mutant genes db(diabetes) and m(misty) on the severity of high-dose streptozotocin diabetes in C57bl/KY mice. Tsitol Genet 25:58–61, 1991 (in Russian).

    Google Scholar 

  59. Bloch KO, Bloch OV, Poltorak VV, et al. The effect of irradiation on the development of streptozotocin diabetes in C57BL/KsJY mice heterozygous and homozygous for gene db (diabetes). Radiobiologiia 31:43–7, 1991 (in Russian).

    Google Scholar 

  60. Stumbles PA, Penhaie WJ. IDDM in rats induced by thymectomy and irradiation. Diabetes 42:571–8, 1993.

    Article  PubMed  CAS  Google Scholar 

  61. Bloch KO, Bloch OV. Influence of mutant gene db on radiosensibility of C57BL/KsJY mice. First All-Union Radiobiology Congress, Moscow, 2:43–4, 1989.

    Google Scholar 

  62. Ikeda T, Takeuchi T, Ito Y, et al. Potentiating effect of glibenclamide on the occurrence of streptozotocin diabetes. Horm Metab Res 18:352, 1986.

    Article  PubMed  CAS  Google Scholar 

  63. Sodoyez JC, Sodoyez-Gofflaux F, Dunbar JC, et al. Reduction in the activity of the pancreatic islets induced in normal rodents by prolonged treatment with derivatives of sulfonylurea. Diabetes 19:603–9, 1970.

    PubMed  CAS  Google Scholar 

  64. Gladkikh AI, Poltorak VV, Brindak Ol, et al. Effect of gene db dose on the development of beta-cytotropic and immunotropic effects of long-term glibenclamide administration in C57BL/KsJY mice. Tsitol Genet 26:20–6, 1992 (in Russian).

    PubMed  CAS  Google Scholar 

  65. Wyse BM, Dulin WE. The influence of age and dietary conditions on diabetes in the db mouse. Diabetologia 6:267–73, 1977.

    Google Scholar 

  66. Leiter EH, Coleman DL, Eisenstein AB, et al. Dietary control of pathogenesis in C57BL/KsJ db/db diabetes mice. Metabolism 30:554–62, 1981.

    Article  PubMed  CAS  Google Scholar 

  67. Leiter EH, Coleman DL, Ingram DK, et al. Influence of dietary carbohydrate on the induction of diabetes in C57BL/KsJ db/db diabetes mice. J Nutr 113:184–95, 1983.

    PubMed  CAS  Google Scholar 

  68. Shafrir E. Nonrecognition of insulin as gluconeogenesis suppressant—a manifestation of selective hepatic insulin resistance in several animal species with type II diabetes: Sand rats, spiny mice and db/db mice. In: Lessons from animal diabetes. Shafrir E, Renold AE, eds. Libbey, London, 2:304–15, 1988.

    Google Scholar 

  69. Montgomery LB, Loria RM, Chinchilli VM. Immunodeficiency as primary phenotype of diabetes mutation db. Studies with coxsachievirus B4. Diabetes 39:675–82, 1990.

    Article  PubMed  CAS  Google Scholar 

  70. Coleman DL. Lessons from studies with genetic forms of diabetes in the mouse. Metabolism 32:162–4, 1983.

    Article  PubMed  CAS  Google Scholar 

  71. Rayfield EJ, Seto Y, Goldberg SL, et al. Venezuelan encephalitis virus-induced alterations in carbohydrate metabolism in genetically diabetic mice. Diabetes 28:799–803, 1979.

    PubMed  CAS  Google Scholar 

  72. Webb SR, Loria RM, Madge GE, et al. Susceptibility of mice to group B Coxsackie virus is influenced by the diabetic gene. J Exp Med 143:1239–18, 1976.

    Article  PubMed  CAS  Google Scholar 

  73. Loria RM, Montgomery LB, Corey LA, et al. Influence of diabetes mellitus heredity on susceptibility to coxsackievirus B4. Arch Virol 81:251–62, 1984.

    Article  PubMed  CAS  Google Scholar 

  74. Quatraro A, Consoli G, Ceriello A, et al. Heterogeneity of diabetes mellitus [letter]. Diabetologia 30:678–9, 1987.

    PubMed  CAS  Google Scholar 

  75. Groop L, Miettinen A, Groop PH, et al. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes 37:99–103, 1988.

    Article  PubMed  CAS  Google Scholar 

  76. Dunaif A. Insulin resistance in polycystic ovarian syndrome. Ann NY Acad Sci 687:60–4, 1993.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Schneider’s Children Medical Center, The National Center for Childhood Diabetes, Petah-Tikvah, Israel

    Dr. Konstantin Bloch & Pnina Vardi

  2. Schneider’s Children Medical Center, National Center for Childhood Diabetes, Kaplan 14, Petah-Tikvah, Israel

    Dr. Konstantin Bloch

Authors
  1. Dr. Konstantin Bloch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pnina Vardi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biochemistry, Hadassah Medical Center, POB 12000, IL 91120, Jerusalem, Israel

    Eleazar Shafrir

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Birkhäuser Boston

About this chapter

Cite this chapter

Bloch, K., Vardi, P. (1996). Role of immune and non-immune aspects of genetics in different expressions of diabetes in db/db mice. In: Shafrir, E. (eds) Lessons from Animal Diabetes VI. Rev.Ser.Advs.Research Diab.Animals (Birkhäuser), vol 6. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4112-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4112-6_18

  • Publisher Name: Birkhäuser Boston

  • Print ISBN: 978-1-4612-8658-5

  • Online ISBN: 978-1-4612-4112-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation